Drug recall D-0220-2026
Product
Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01
Reason for recall
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Lots and codes
Lot #: WB00006, Exp 12/31/2026
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Naples, FL
- Quantity
- 32736 vials
- Distribution
- FL, MA, MI & OH
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 13, 2025
Related products
- Ganirelix Acetate – drug information
- NDC 70748-274 Ganirelix Acetate · Ganirelix Acetate 250 ug/.5mL · Lupin Pharmaceuticals, Inc.